Aquestive Therapeutics Statistics

Total Valuation

AQST has a market cap or net worth of $271.17 million. The enterprise value is $229.72 million.

Market Cap	271.17M
Enterprise Value	229.72M

Important Dates

The last earnings date was Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

AQST has 99.33 million shares outstanding. The number of shares has increased by 40.22% in one year.

Current Share Class	99.33M
Shares Outstanding	99.33M
Shares Change (YoY)	+40.22%
Shares Change (QoQ)	+4.71%
Owned by Insiders (%)	5.85%
Owned by Institutions (%)	47.74%
Float	93.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.34
Forward PS	3.99
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.87

Current Ratio	4.87
Quick Ratio	4.32
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.44

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-22.21%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-49.06%
Revenue Per Employee	$381,887
Profits Per Employee	-$381,965
Employee Count	142
Asset Turnover	0.47
Inventory Turnover	2.30

Taxes

Income Tax	-14,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.78% in the last 52 weeks. The beta is 2.02, so AQST's price volatility has been higher than the market average.

Beta (5Y)	2.02
52-Week Price Change	-10.78%
50-Day Moving Average	2.72
200-Day Moving Average	3.72
Relative Strength Index (RSI)	55.40
Average Volume (20 Days)	1,782,957

Short Selling Information

The latest short interest is 9.41 million, so 9.47% of the outstanding shares have been sold short.

Short Interest	9.41M
Short Previous Month	9.87M
Short % of Shares Out	9.47%
Short % of Float	10.06%
Short Ratio (days to cover)	7.67

Income Statement

In the last 12 months, AQST had revenue of $54.23 million and -$54.24 million in losses. Loss per share was -$0.59.

Revenue	54.23M
Gross Profit	37.09M
Operating Income	-41.18M
Pretax Income	-25.76M
Net Income	-54.24M
EBITDA	-40.51M
EBIT	-41.18M
Loss Per Share	-$0.59

Full Income Statement

Balance Sheet

The company has $68.66 million in cash and $39.14 million in debt, giving a net cash position of $29.52 million or $0.30 per share.

Cash & Cash Equivalents	68.66M
Total Debt	39.14M
Net Cash	29.52M
Net Cash Per Share	$0.30
Equity (Book Value)	-60.93M
Book Value Per Share	-0.61
Working Capital	70.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$48.78 million and capital expenditures -$265,000, giving a free cash flow of -$49.04 million.

Operating Cash Flow	-48.78M
Capital Expenditures	-265,000
Free Cash Flow	-49.04M
FCF Per Share	-$0.49

Full Cash Flow Statement

Margins

Gross margin is 68.40%, with operating and profit margins of -75.94% and -100.02%.

Gross Margin	68.40%
Operating Margin	-75.94%
Pretax Margin	-100.05%
Profit Margin	-100.02%
EBITDA Margin	-74.70%
EBIT Margin	-75.94%
FCF Margin	n/a

Dividends & Yields

AQST does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-40.22%
Shareholder Yield	-40.22%
Earnings Yield	-20.92%
FCF Yield	-18.92%

Analyst Forecast

The average price target for AQST is $11.40, which is 317.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.40
Price Target Difference	317.58%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	35.05%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AQST has an Altman Z-Score of -4 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4
Piotroski F-Score	2